slides · global inventory
Title
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 303,780
Current window 28,861-28,890
Pages 10,126
Rows per page 30
Component
28,861-28,890 of 303,780
147
The slide uses a table to highlight inconsistencies in clinical trial data to suggest misclassification of medical outcomes.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 2 hits
148
The slide uses a table to map shared mechanisms of edema between GH and Diazoxide, and a second table to highlight the high prevalence of GH use in the P3 study.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 2 hits
151
The slide uses expert testimony to highlight a potential safety concern (edema) and suggests the company is downplaying or managing it in an unusual way.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 2 hits
206
The slide uses a visual callout (yellow box) to highlight the specific data column in the table that contradicts the plotted graph.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 2 hits
210
The slide uses two charts to illustrate why XR is ineffective for this specific drug profile.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 2 hits
214
The slide uses molecular weight calculations to expose that DCCR is simply a salt form of diazoxide, implying the price premium is unjustified.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 2 hits
263
Includes a screenshot of a blog post and two photos of the doctor interacting with a child.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 2 hits
267
The slide uses a combination of narrative text, a screenshot of a YouTube video, and snippets of press articles to build a case of poor judgment or questionable association.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 2 hits
272
The slide uses red arrows to connect the two associations to the town hall event flyer.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 2 hits
305
The slide uses direct quotes from a trial investigator to undermine the drug's market potential and clinical efficacy.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 2 hits
01
The slide uses aggressive, accusatory language typical of short-seller research reports.Lasertec Corporation (6920) · Scorpion Capital
Research note Short seller Beat · The Monster2 hits
05
The slide uses a comparative analysis against industry peers and historical data to highlight the anomaly of the inventory levels.Lasertec Corporation (6920) · Scorpion Capital
Research note Short seller Beat · The MonsterLoop · Aha Moment2 hits
06
The slide uses strong, accusatory language to frame the company's financial reporting as fraudulent.Lasertec Corporation (6920) · Scorpion Capital
Research note Short seller Beat · The MonsterLoop · Aha Moment2 hits
07
The slide uses a 'fraud-exposure' narrative, highlighting anomalies in financial metrics (EBIT margins, cash conversion) and physical site observations.Lasertec Corporation (6920) · Scorpion Capital
Research note Short seller Beat · The MonsterLoop · Aha Moment2 hits
08
The slide uses comparative analysis against industry peers (ASML, Applied Materials, Lam, KLA) and historical precedents (Toshiba, MagnaChip) to build a case for financial manipulation.Lasertec Corporation (6920) · Scorpion Capital
Research note Short seller Beat · The MonsterLoop · Aha Moment2 hits
09
The slide uses a 'fraud-exposure' framework to argue that inventory valuation is being manipulated to avoid impairment charges.Lasertec Corporation (6920) · Scorpion Capital
Research note Short seller Beat · The MonsterLoop · Aha Moment2 hits
11
The slide uses strong, accusatory language ('fatally flawed', 'furious', 'terrible') to frame the technical issues as a business crisis.Lasertec Corporation (6920) · Scorpion Capital
Research note Short seller Beat · The StruggleLoop · Aha Moment2 hits
12
The slide uses direct quotes from field service and application engineers to substantiate claims of product defects.Lasertec Corporation (6920) · Scorpion Capital
Research note Short seller Beat · The StruggleLoop · Aha Moment2 hits
13
The slide uses heavy anecdotal evidence and expert quotes to build a case against the product's viability.Lasertec Corporation (6920) · Scorpion Capital
Research note Short seller Beat · The StruggleLoop · Aha Moment2 hits
14
The slide uses anecdotal evidence and expert quotes to build a case against the product's viability.Lasertec Corporation (6920) · Scorpion Capital
Research note Short seller Beat · The StruggleLoop · Aha Moment2 hits
15
The slide uses expert testimony and industry comparisons to frame Lasertec's product as inferior to ASML's technology.Lasertec Corporation (6920) · Scorpion Capital
Research note Short seller Beat · The StruggleLoop · Aha Moment2 hits
17
The slide uses investigative journalism techniques to build a case of corporate deception.Lasertec Corporation (6920) · Scorpion Capital
Research note Short seller Beat · The Struggle2 hits
18
The slide uses direct quotes from an Ushio engineer and other industry experts to undermine Lasertec's marketing claims.Lasertec Corporation (6920) · Scorpion Capital
Research note Short seller Beat · The Struggle2 hits
19
The slide uses expert quotes and technical reasoning to discredit a competitor's product claims.Lasertec Corporation (6920) · Scorpion Capital
Research note Short seller Beat · The Struggle2 hits
20
The slide uses a series of bullet points to build a case of fraud/misrepresentation against Lasertec's product claims.Lasertec Corporation (6920) · Scorpion Capital
Research note Short seller Beat · The StruggleLoop · Cost Of Inaction2 hits
22
The slide uses expert testimony to frame Lasertec's technical roadmap as a failure, specifically highlighting the inadequacy of their R&D investment compared to ASML/Cymer.Lasertec Corporation (6920) · Scorpion Capital
Research note Short seller Beat · The StruggleLoop · Cost Of Inaction2 hits
23
The slide relies on primary source interviews with an Isteq engineer to discredit Lasertec's technical capabilities.Lasertec Corporation (6920) · Scorpion Capital
Research note Short seller Beat · The StruggleLoop · Cost Of Inaction2 hits
24
The slide uses a narrative approach to discredit Lasertec's technical strategy by highlighting past rejections of current partners.Lasertec Corporation (6920) · Scorpion Capital
Research note Short seller Beat · The StruggleLoop · Cost Of Inaction2 hits
26
Includes direct quotes from industry experts regarding customer sentiment and the competitive landscape for EUV mask inspection tools.Lasertec Corporation (6920) · Scorpion Capital
Research note Short seller Beat · The StruggleLoop · Cost Of Inaction2 hits
28
The slide uses investigative journalism techniques to expose potential corporate obfuscation regarding technical performance.Lasertec Corporation (6920) · Scorpion Capital
Research note Short seller Beat · The StruggleLoop · Cost Of Inaction2 hits